Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
610.4 INR | -1.97% |
|
-3.41% | -15.93% |
May. 30 | Transcript : Suven Pharmaceuticals Limited, Q4 2024 Earnings Call, May 30, 2024 | |
Mar. 27 | Suven Pharmaceuticals Limited Announces Shifting of Registered Office | CI |
Sales 2023 | 13.4B 161M | Sales 2024 * | 10.9B 131M | Capitalization | 155B 1.87B |
---|---|---|---|---|---|
Net income 2023 | 4.11B 49.52M | Net income 2024 * | 3.34B 40.23M | EV / Sales 2023 | 8.97 x |
Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 14.3 x |
P/E ratio 2023 |
29.2
x | P/E ratio 2024 * |
46.4
x | Employees | 1,193 |
Yield 2023 * |
0.38% | Yield 2024 * |
0.29% | Free-Float | 37.48% |
Latest transcript on Suven Pharmaceuticals Limited
1 day | -1.97% | ||
1 week | -3.41% | ||
Current month | -1.97% | ||
1 month | -8.82% | ||
3 months | -15.65% | ||
6 months | -9.44% | ||
Current year | -15.93% |
![Extreme 597.35](/images/extremecours_fleche.png)
![Extreme 597.35](/images/extremecours_fleche.png)
![Extreme 586.1](/images/extremecours_fleche.png)
![Extreme 427.05](/images/extremecours_fleche.png)
![Extreme 375](/images/extremecours_fleche.png)
![Extreme 87.05](/images/extremecours_fleche.png)
![Extreme 87.05](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Sudhir Singh
CEO | Chief Executive Officer | - | 23-09-28 |
Himanshu Agarwal
DFI | Director of Finance/CFO | 30 | Dec. 31 |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 67 | 23-09-28 | |
Shweta Jalan
BRD | Director/Board Member | 48 | Nov. 08 |
Director/Board Member | 62 | Nov. 08 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-03 | 610.4 | -1.97% | 19 178 |
24-05-31 | 622.7 | -1.34% | 21,511 |
24-05-30 | 631.2 | -2.45% | 2,259 |
24-05-29 | 647 | +0.65% | 4,321 |
24-05-28 | 642.8 | +1.53% | 4,417 |
Delayed Quote Bombay S.E., June 03, 2024 at 06:00 am EDT
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+42.63% | 739B | |
+32.34% | 598B | |
-5.69% | 353B | |
+17.52% | 318B | |
+3.24% | 285B | |
+16.47% | 240B | |
+9.26% | 210B | |
-5.07% | 206B | |
+6.96% | 164B |
- Stock Market
- Equities
- SUVENPHAR Stock
- SUVENPHAR Stock